TORONTO, ON -- Sept. 18, 2018 --
InvestorsHub NewsWire -- Maricann Group Inc. (CSE:MARI) (FRANKFURT: 75M) (OTCQB:MRRCF) (the "Company")
through its wholly-owned subsidiary Maricann Inc. proudly announces
the launch of Kiwi - a straightforward, modern approach to cannabis
and the first from the Company's House of Brands - available to
Canadian consumers of legal age on October 17,
2018.
Maricann is launching Kiwi as a brand designed to
help Canadians learn and experience the product in a
straightforward, simple and "jargon-free" way. Rather than
launching with technical strains that might confuse new consumers,
Kiwi will debut four variants that are easy to follow, regardless
of background or expertise. Available in dried flower formats,
Kiwi's simple naming system consists of White Feather (High CBD),
Hawke's Bay (Balanced), Nelson's Blue (Mid THC) and Flightless Bird
(Mid-High THC), which are playful takes on Kiwi's New
Zealand-inspired name. Each strain will deliver reliable,
consistent sensations that are easy to enjoy.
"We're in the middle of a rapidly growing
industry; one that has sparked a lot of curiosity among consumers.
We've built Kiwi to streamline the information and clutter of
products - so that cannabis is accessible to a wider public and
Canadians can make smart, informed decisions on where we fit in
their wellness routine and lifestyle," said Geoff Kosar, Vice
President of Sales & Marketing. "At its core, Kiwi is a
celebration of the simple pleasures, and that starts with simple,
straightforward communications."
Working as Kiwi's Master Grower, industry veteran
Jennifer Ayotte brings her exacting standards and dedication to
delivering quality cannabis to Maricann's state-of-the-art
facilities in Langton, Ontario. "Cannabis can be simple, elegant
and easy-to-understand," said Jennifer Ayotte, Kiwi Master Grower.
"When the right measures are set in place for consistency, quality
and safety, it's easier to see that what we're really talking about
are plants."
Visit kiwicannabis.ca for more
information on how to simplify your self-care.
For further information or media inquiries,
contact:
Sierra Percy-Beauregard | sierra@acteam.ca or visit
Kiwi's website.
About Maricann Group
Inc.
Maricann is a vertically integrated producer and
distributor of cannabis for medical purposes. The Company was
founded in 2013 and is based in Burlington, Ontario, Canada and
Munich, Germany, with production facilities in Langton, Ontario
where it operates a medicinal cannabis cultivation, extraction,
formulation and distribution business under federal licence from
the Government of Canada. The Company also has production
operations in Dresden, Saxony, Germany and Regensdorf, Switzerland.
Maricann is currently undertaking an expansion of its cultivation
and support facilities in Canada in a 942,000 sq. ft. (87,515 sq.
m) and will continue to pursue new opportunities in
Europe.
Forward Looking
Statements
This news release includes forward-looking
information and statements, which may include, but are not limited
to, information and statements regarding or inferring the future
business, operations, financial performance, prospects, and other
plans, intentions, expectations, estimates, and beliefs of the
Company. Forward-looking information and statements involve and are
subject to assumptions and known and unknown risks, uncertainties,
and other factors which may cause actual events, results,
performance, or achievements of the Company to be materially
different from future events, results, performance, and
achievements expressed or implied by forward-looking information
and statements herein. Although the Company believes that any
forward-looking information and statements herein are reasonable,
in light of the use of assumptions and the significant risks and
uncertainties inherent in such information and statements, there
can be no assurance that any such forward-looking information and
statements will prove to be accurate, and accordingly readers are
advised to rely on their own evaluation of such risks and
uncertainties and should not place undue reliance upon such
forward-looking information and statements. Any forward-looking
information and statements herein are made as of the date hereof,
and except as required by applicable laws, the Company assumes no
obligation and disclaims any intention to update or revise any
forward-looking information and statements herein or to update the
reasons that actual events or results could or do differ from those
projected in any forward looking information and statements herein,
whether as a result of new information, future events or results,
or otherwise, except as required by applicable
laws.
The Canadian
Securities Exchange has not reviewed, approved or disapproved the
content of this news release.
For more information about Maricann, please visit
our website at www.maricann.com
CONTACT
INFORMATION
Investor Relations
Graham Farrell
VP, Communications
graham@maricann.com
647-643-7665
Corporate Headquarters (Canada)
Maricann Group Inc. (Toronto)
845 Harrington Court, Unit 3
Burlington Ontario L7N 3P3
Canada
289-288-6274
European Headquarters (Germany)
Maricann GmbH
Thierschstrasse 3, 80538 Munchen,
Deutschland